Telmisartan Recruiting Phase N/A Trials for Graft Versus Host Disease (GVHD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT02338232Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation